References
- Bonadonna G, Valagussa P. Adjuvant therapy of primary breast cancer. In: Carter SK, Glatstein E. Livingston RB, eds. Principles of cancer treatment. New York: McGraw-Hill, 1981: 315–26
- Bonadonna G. Overview of adjuvant chemotherapy. Presented as part of the General Symposium on Advances in Specific Therapeutic Modalities. 13th International Cancer Congress, Seattle, 1982
- Mitchell MS. A note on the lymph node as an immunological barrier. In: Weiss L, Gilbert HA, Ballon SC, eds. Lymphatic system metastasis. Boston: GK Hall, 1980: 74–9
- Haskell CM, Sparks FC, Thompson RW. Breast cancer. In: Haskell CM, ed. Cancer treatment, Philadelphia: WB Saunders. 1980: 159–96
- Fisher B, Redmond C, Wolmark N. Breast cancer studies of the NSABP: an editorialized review. In: Salmon SE, Jones SE, eds. Adjuvant therapy of cancer III. New York: Grune & Stratton, 1981: 359–69
- Howat JM, Hughes R. Dunning P, et al. A controlled clinical trial of adjuvant chemotherapy in operable cancer of the breast. In: Salmon et al. eds.5 pp 371–6
- Buzdar A, Smith T, Blumenschein G, et al. Adjuvant chemotherapy with fluorouracil, doxorubicin and cyclophosphamide (FAC) for stage II or III breast cancer: 5-year results In: Salmon et al, eds.5 pp 419–26
- Jones S, Moon T, Davis S, et al. Comparative analysis of selected breast cancer adjuvant trials in relation to the natural history data base (NHDB). In: Salmon et al, eds.5 pp 483–92
- Cooper RG, Holland JF, Glidewell O. Adjuvant chemotherapy of breast cancer. Cancer 1979: 44(3): 793–8
- Tancini G, Bajetta E, Marchini S, et al. Preliminary 3-year results of 12 versus 6 cycles of surgical adjuvant CMF in premenopausal breast cancer. Cancer Clin Trials 1979: 2(4): 285–92
- Valagussa P, diFronzo G, Bignami P, et al. Prognostic importance of estrogen receptors to select node negative patients for adjuvant chemotherapy. In: Salmon et al. eds.5 pp 329–33
- Bonadonna G, Valaguasa P, de Palo G. The results of adjuvant chemotherapy are predominantly caused by the hormonal changes such therapy induces: the view against. In: Van Scoy-Mosher MB. Controversies in medical oncology. Boston: GK Hall, 1981: 100–9
- Rivkin S, Glucksberg H, Foulkes M. Adjuvant chemotherapy for operable breast cancer with positive axillary nodes. Proc Amer Soc Clin Oncol 1982: 23: 74
- Tormey DC, Holland JF, Weinberg V, et al. 5-Drug vs 3-Drug + MER postoperative chemotherapy for mammary carcinoma. In: Salmon et al. eds,5 pp 377–83
- Davis HL, Metter GE, Ramirez G, et al. An adjuvant trial of L-Phenylalanine mustard (L-PAM) vs cyclophosphamide (C). Methotrexate (M), 5-Fluourouracil (S), and Vincristine (V)-CMV-V following mastectomy for operable breast cancer. Proc Am Soc Clin Oncol 1979: 20: 358
- Palshof T, Mouridsen HT, Daehnfeldt JL. Adjuvant endocrine therapy of primary operable breast cancer. In: Mouridsen HT, Palshof T, eds. Breast cancer, experimental and clinical aspects. Proceedings, second E.O.R.T.C. (European Organization for Research on Treatment of Cancer) Breast Cancer Working Conference. Copenhagen. May 30-Jun 2. 1979. Elmsford, NY: Pergamon. 1980: 183–7
- Hubay CA, Pearson OH, Marshall JS, et al. Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer. In: Mouridsen, Palshof, eds.16 pp 189–95
- Fisher B, Redmond C, Brown A, et al. Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med 1981: 305(1): 1–6
- Smalley RV. The management of disseminated breast cancer. In: Carter et al. eds.1 pp 327–41
- McGuire WL, Horwitz KB, Pearson OH, et al. Current status of estrogen and progesterone receptors in breast cancer. Cancer 1977: 39(6 Suppl): 2934–47
- Ingle JN, Ahmann DL, Green SJ, et al. Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. N Engl J Med 1981: 304(1): 16–21
- Gutterman JU, Blumenschein GR, Alexanian R, et al. Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma and malignant lymphoma. Ann Intern Med 1980: 93(3): 399–406
- Terman DS, Young JB, Shearer WT, et al. Preliminary observations of the effects on breast adenocarcinoma of plasma perfused over immobilized protein A. N Engl J Med 1981: 305(20): 1195–200